Intravitreal Infliximab for the Treatment of Proliferative Vitreoretinopathy Associated with Rhegmatogenous Retinal Detachment: The Phase II FIXER Trial

  • Ayman Elnahry, MD, PhD
  • Video
  • Published 2023

See more